Anika Therapeutics (ANIK) Amortization of Goodwill (2020)

Anika Therapeutics (ANIK) reported Amortization of Goodwill of $24.4 million for Q4 2020.

Anika Therapeutics (ANIK) Amortization of Goodwill (2020) Analysis & Trends

Anika Therapeutics (ANIK) has 1 years of Amortization of Goodwill data on file, last reported at $24.4 million in Q4 2020.

  • Amortization of Goodwill for Q4 2020 came in at $24.4 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2021 was $24.4 million (changed N/A YoY), and the FY2020 annual result was $42.5 million, changed N/A from the prior year.
  • Amortization of Goodwill held at $24.4 million in Q4 2020 per ANIK's latest filing.
  • Over five years, Amortization of Goodwill peaked at $24.4 million in Q4 2020 and troughed at $24.4 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Anika Therapeutics 197.89 Mn 131.10 Mn 19.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2020 24.40 Mn
Dec 31, 2020 24.40 Mn